Iris Karina Madera-Salcedo

Iris Karina Madera-Salcedo

Auto-generated profile, based on publicly available information

Iris Karina Madera-Salcedo

Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, 14080, Mexico

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
VMVijayashree Mysore
Vijayashree Mysore
XCXavier Cullere
Xavier Cullere
JMJoseph Mears
Joseph Mears
FRFlorencia Rosetti
Florencia Rosetti
KOKoshu Okubo
Koshu Okubo
TMTanya N. Mayadas
Tanya N. Mayadas
Classical dendritic cells (cDC) are professional antigen-presenting cells (APC) that regulate immunity and tolerance. Neutrophil-derived cells with properties of DCs (nAPC) are observed in human diseases and after culture of neutrophils with cytokines. Here we show that FcγR-mediated endocytosis of antibody-antigen complexes or an anti-FcγRIIIB-antigen conjugate converts neutrophils into nAPCs that, in contrast to those generated with cytokines alone, activate T cells to levels observed with cDCs and elicit CD8+ T cell-dependent anti-tumor immunity in mice. Single cell transcript analyses and validation studies implicate the transcription factor PU.1 in neutrophil to nAPC conversion. In humans, blood nAPC frequency in lupus patients correlates with disease. Moreover, anti-FcγRIIIB-antigen conjugate treatment induces nAPCs that can activate autologous T cells when using neutrophils from individuals with myeloid neoplasms that harbor neoantigens or those vaccinated against bacterial toxins. Thus, anti-FcγRIIIB-antigen conjugate-induced conversion of neutrophils to immunogenic nAPCs may represent a possible immunotherapy for cancer and infectious diseases.

22 September 2014 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
UBUlrich Blank
Ulrich Blank
IMIris Karina Madera-Salcedo
Iris Karina Madera-Salcedo
LDLuca Danelli
Luca Danelli
JCJulien Claver
Julien Claver
NTNeeraj Tiwari
Neeraj Tiwari
CGClaudia González-Espinosa
Claudia González-Espinosa
Upon activation mast cells (MC) secrete numerous inflammatory compounds stored in their cytoplasmic secretory granules (SG) by a process called anaphylactic degranulation, which is responsible for type I hypersensitivity responses. Prestored mediators include histamine and mast cell proteases but also some cytokines and growth factors making them available within minutes for a maximal biological effect. Degranulation is followed by the de novo synthesis of lipid mediators such as prostaglandins and leukotrienes as well as a vast array of cytokines, chemokines and growth factors, which are responsible for late phase inflammatory responses. While lipid mediators diffuse freely out of the cell through lipid bilayers, both anaphylactic degranulation and secretion of cytokines, chemokines and growth factors depends on highly regulated vesicular trafficking steps that occur along the secretory pathway starting with the translocation of proteins to the ER. Vesicular trafficking in mast cells also intersects with endocytic routes, notably to form specialized cytoplasmic granules called secretory lysosomes. Some of the mediators like histamine reach granules via specific vesicular monoamine transporters directly from the cytoplasm. In this review, we try to summarize the available data on granule biogenesis and signaling events that coordinate the complex steps that lead to the release of the inflammatory mediators from the various vesicular carriers in mast cells.

15 September 2013 in The Journal of Immunology
Verified
Journal Article
Closed access
IMIris K Madera-Salcedo
Iris K Madera-Salcedo
SCSilvia Lorenia Cruz
Silvia Lorenia Cruz
CGClaudia González-Espinosa
Claudia González-Espinosa
We have previously shown that morphine pretreatment inhibits mast cell–dependent TNF production after LPS injection in the murine peritoneal cavity. In this study, we used bone marrow–derived mast cells (BMMCs) to investigate the molecular mechanisms of that inhibition. We found that morphine prevented LPS-induced TNF secretion in these cells. The observed inhibition was not due to morphine-induced TLR4 internalization and it was related to the blockage of preformed TNF secretion. LPS-induced TNF exocytosis in BMMCs was dependent on tetanus toxin–insensitive vesicle-associated membrane proteins and calcium mobilization, as well as PI3K, MAPK, and IκB kinase (IKK) activation. TNF secretion was also associated to the phosphorylation of synaptosomal-associated protein 23 (SNAP-23), which was found forming a complex with IKK in LPS-activated BMMCs. Morphine pretreatment prevented TLR4-dependent ERK and IKK phosphorylation. Analyzing the signaling events upstream of IKK activation, we found diminished TGF-β–activated kinase 1 (TAK1) phosphorylation and TNFR-associated factor (TRAF) 6 ubiquitination in BMMCs pretreated with morphine and stimulated with LPS. Morphine pretreatment provoked a marked increase in the formation of a molecular complex composed of TRAF6 and β-arrestin-2. Naloxone and a combination of μ and δ opioid receptor antagonists prevented morphine inhibitory actions. In conclusion, our results show that activation of μ and δ opioid receptors with morphine suppresses TLR4-induced TNF release in mast cells, preventing the IKK-dependent phosphorylation of SNAP-23, which is necessary for TNF exocytosis, and this inhibition correlates with the formation of a β-arrestin-2/TRAF6 complex. To our knowledge, these findings constitute the first evidence of molecular crosstalk between opioid receptors and the TLR4 signal transduction system in mast cells.


24 October 2016 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
IMIsabelle Munoz
Isabelle Munoz
LDLuca Danelli
Luca Danelli
JCJulien Claver
Julien Claver
NGNicolas Goudin
Nicolas Goudin
MKMathieu Kurowska
Mathieu Kurowska
GMGaël Ménasché
Gaël Ménasché
Cross-linking of mast cell (MC) IgE receptors (FcεRI) triggers degranulation of secretory granules (SGs) and the release of many allergic and inflammatory mediators. Although degranulation depends crucially on microtubule dynamics, the molecular machinery that couples SGs to microtubule-dependent transport is poorly understood. In this study, we demonstrate that mice lacking Kif5b (the heavy chain of kinesin-1) in hematopoietic cells are less sensitive to IgE-mediated, passive, systemic anaphylaxis. After IgE-induced stimulation, bone marrow–derived MCs from Kif5b knockout mice exhibited a marked reduction in SG translocation toward the secretion site. In contrast, a lack of Kif5b did not affect cytokine secretion, early FcεRI-initiated signaling pathways, or microtubule reorganization upon FcεRI stimulation. We identified Slp3 as the critical effector linking kinesin-1 to Rab27b-associated SGs. Kinesin-1 recruitment to the Slp3/Rab27b effector complex was independent of microtubule reorganization but occurred only upon stimulation requiring phosphatidylinositol 3-kinase (PI3K) activity. Our findings demonstrate that PI3K-dependent formation of a kinesin-1/Slp3/Rab27b complex is critical for the microtubule-dependent movement of SGs required for MC degranulation.

1 January 2015 in Molecular Immunology
Verified
Journal Article
Closed access
LMLydia Celia Madjene
Lydia Celia Madjene
MPMaguelonne Pons
Maguelonne Pons
LDLuca Danelli
Luca Danelli
JCJulien Claver
Julien Claver
LALiza Ali
Liza Ali
UBUlrich Blank
Ulrich Blank